Loading clinical trials...
Loading clinical trials...
An Observational, Multicenter Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)
Conditions
Interventions
Blood Draws
Data Collection
Locations
1
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
October 13, 2016
Primary Completion Date
January 29, 2020
Completion Date
January 29, 2020
Last Updated
September 19, 2024
NCT05841342
NCT01998633
NCT05384743
NCT04077905
NCT01818908
NCT03742115
Lead Sponsor
Swedish Orphan Biovitrum
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions